Synthetic cannabinoid receptor agonists profile in infused papers seized in Brazilian prisons

被引:18
|
作者
Rodrigues, Tais B. [1 ]
Souza, Monica P. [2 ]
de Melo Barbosa, Lilian [3 ]
de Carvalho Ponce, Julio [3 ]
Neves Junior, Luiz F. [3 ]
Yonamine, Mauricio [4 ]
Costa, Jose Luiz [1 ,5 ]
机构
[1] Univ Estadual Campinas, Campinas Poison Control Ctr, BR-13083859 Campinas, SP, Brazil
[2] Brazilian Fed Police, Natl Inst Criminalist, BR-70610200 Brasilia, DF, Brazil
[3] Inst Criminalist, Superintendence Tech Sci Police, BR-05507060 Sao Paulo, SP, Brazil
[4] Univ Sao Paulo, Sch Pharmaceut Sci, BR-05508000 Sao Paulo, SP, Brazil
[5] Univ Estadual Campinas, Fac Pharmaceut Sci, BR-13083871 Campinas, SP, Brazil
关键词
Synthetic cannabinoid receptor agonists; New psychoactive substances (NPS); 5F-MDMB-PICA; MDMB-4en-PINACA; Abuse in prisons; 25I-NBOH;
D O I
10.1007/s11419-021-00586-7
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
Purpose Synthetic cannabinoid receptor agonists (SCRAs) are a class of varied compounds that mimic the effects of natural cannabinoids found in cannabis. Because they have a wide range of diverse structures, they vary widely in their potency. The abuse of new psychoactive substances (NPS) in prisons was reported in many European countries and in the USA. In the present study, we have described the identification of SCRAs in 56 infused paper sheet samples, seized mainly in Brazilian prisons between 2016 and 2020. Methods The materials were seized by local or federal law enforcement and analyzed by Sao Paulo State Police or Brazilian Federal Police using gas chromatography-mass spectrometry, attenuated total reflection-Fourier transform infrared spectroscopy, liquid chromatography-high-resolution mass spectrometry or nuclear magnetic resonance spectrometry. Results Most of these samples (87.5%) were seized in 2019-2020; seven different SCRAs were identified in samples, and the most frequently identified substances were MDMB-4en-PINACA (23.6%) and 5F-MDMB-PICA (36.4%), the newest SCRAs emerging recently. Conclusions As observed in Europe and the USA, Brazil also shows the prevalence of indazole-3-carboxamides and indole-3-carboxamides among SCRAs seizures in the prison system. This phenomenon is spreading all over the world at this moment. These data on the prevalence could help to alert judicial authorities to shutting down the introduction of NPS, including SCRAs, into prisons to ensure safety and security for avoiding health risks of prisoners and staff, leading to positive effects in this population. To our knowledge, this is the first demonstration of SCRAs smuggling into prisons in Latin America.
引用
收藏
页码:119 / 124
页数:6
相关论文
共 50 条
  • [41] Changing patterns of synthetic cannabinoid receptor agonists encountered in UK Emergency Departments
    Thomas, Simon H. L.
    Vidler, Dan
    Officer, Jane
    Hardy, Gareth
    Eddleston, Michael
    Dargan, Paul I.
    Cooper, Jamie
    Haden, Mark
    Hill, Simon L.
    Keating, Liza
    Issa, Shabanna
    Ketchin, Andy
    Macfarlane, Rebecca
    Hudson, Simon
    CLINICAL TOXICOLOGY, 2021, 59 (06) : 538 - 538
  • [42] Synthetic cannabinoid receptor agonists inhibit tumor growth and metastasis of breast cancer
    Qamri, Zahida
    Preet, Anju
    Nasser, Mohd W.
    Bass, Caroline E.
    Leone, Gustavo
    Barsky, Sanford H.
    Ganju, Ramesh K.
    MOLECULAR CANCER THERAPEUTICS, 2009, 8 (11) : 3117 - 3129
  • [43] Investigating selectivity and bias for G protein subtypes and β-arrestins by synthetic cannabinoid receptor agonists at the cannabinoid CB1 receptor
    Ryalls, Beth
    Patel, Monica
    Sparkes, Eric
    Banister, Samuel D.
    Finlay, David B.
    Glass, Michelle
    BIOCHEMICAL PHARMACOLOGY, 2024, 222
  • [44] In vitro cannabinoid activity profiling of generic ban-evading brominated synthetic cannabinoid receptor agonists and their analogs
    Deventer, Marie H.
    Persson, Mattias
    Norman, Caitlyn
    Liu, Huiling
    Connolly, Matthew J.
    Daeid, Niamh Nic
    McKenzie, Craig
    Green, Henrik
    Stove, Christophe P.
    DRUG TESTING AND ANALYSIS, 2024, 16 (06) : 616 - 628
  • [45] In vitro cannabinoid receptor activity, metabolism, and detection in seized samples of CH-PIATA, a new indole-3-acetamide synthetic cannabinoid
    Norman, Caitlyn
    Deventer, Marie H.
    Dremann, Olivia
    Reid, Robert
    Van Uytfanghe, Katleen
    Guillou, Claude
    Vinckier, Inge M. J.
    Nic Daeid, Niamh
    Krotulski, Alex
    Stove, Christophe P.
    DRUG TESTING AND ANALYSIS, 2024, 16 (04) : 380 - 391
  • [46] Comparing the effects of endogenous and synthetic cannabinoid receptor agonists on survival of gastric cancer cells
    Ortega, A.
    Garcia-Hernandez, V. M.
    Ruiz-Garcia, E.
    Meneses-Garcia, A.
    Herrera-Gomez, A.
    Aguilar-Ponce, J. L.
    Montes-Servin, E.
    Prospero-Garcia, O.
    Del Angel, S. A.
    LIFE SCIENCES, 2016, 165 : 56 - 62
  • [47] Differential activation of G protein-mediated signaling by synthetic cannabinoid receptor agonists
    Sachdev, Shivani
    Banister, Samuel D.
    Santiago, Marina
    Bladen, Chris
    Kassiou, Michael
    Connor, Mark
    PHARMACOLOGY RESEARCH & PERSPECTIVES, 2020, 8 (02):
  • [48] Synthesis and Functional Evaluation of Synthetic Cannabinoid Receptor Agonists Related to ADB-HEXINACA
    Sparkes, Eric
    Timmerman, Axelle
    Markham, Jack W.
    Boyd, Rochelle
    Gordon, Rebecca
    Walker, Katelyn A.
    Kevin, Richard C.
    Hibbs, David E.
    Banister, Samuel D.
    Cairns, Elizabeth A.
    Stove, Christophe
    Ametovski, Adam
    ACS CHEMICAL NEUROSCIENCE, 2024, 15 (09): : 1787 - 1812
  • [49] Forensic patients' experiences of Synthetic Cannabinoid Receptor Agonists (SCRAs) within custodial settings
    Rogers, Gemma
    Rees, Jessica
    Rowe, Sarah
    Tyler, Nichola
    Tracy, Derek K.
    JOURNAL OF FORENSIC PSYCHIATRY & PSYCHOLOGY, 2022, 33 (01): : 152 - 171
  • [50] Increase in Emergency Department presentations in Europe related to the use of synthetic cannabinoid receptor agonists
    Wood, David M.
    Dines, Alison M.
    Hovda, Knut Erik
    Heyerdahl, Fridtjof
    Yates, Christopher
    Giraudon, Isabelle
    Dargan, Paul I.
    CLINICAL TOXICOLOGY, 2017, 55 (05) : 447 - 448